Aurinia Pharmaceuticals
AUPH
AUPH
257 hedge funds and large institutions have $1.09B invested in Aurinia Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 103 increasing their positions, 69 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.53% more ownership
Funds ownership: 55.04% → 55.58% (+0.53%)
5% less capital invested
Capital invested by funds: $1.15B → $1.09B (-$57.9M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
257
Holding in Top 10
2
Calls
$7.87M
Puts
$6.41M
Top Buyers
| 1 | +$21.4M | |
| 2 | +$13.2M | |
| 3 | +$6.83M | |
| 4 |
Goldman Sachs
New York
|
+$6.24M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
+$5.59M |
Top Sellers
| 1 | -$9.08M | |
| 2 | -$7.38M | |
| 3 | -$6.7M | |
| 4 |
Corient Private Wealth
Miami,
Florida
|
-$4.06M |
| 5 |
NICM
Neo Ivy Capital Management
New York
|
-$3.66M |
